Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-06 Purchase |
2021-07-08 5:21 pm |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
450,000 | $14.88 | $6,696,000 | 3,417,075 (Direct) |
View |
| 2021-07-06 Purchase |
2021-07-08 4:32 pm |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,875,000 | $16 | $30,000,000 | 588,850 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2021-07-08 5:59 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
0 | $0 | 131,595 (Indirect) |
View |
| 2021-07-06 Conversion |
2021-07-08 5:21 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
2,967,075 | $0 | 3,417,075 (Direct) |
View |
| 2021-07-06 Conversion |
2021-07-08 4:32 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
7,895,773 | $0 | 588,850 (Indirect) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:21 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Stoppel Laura Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:20 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:19 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:18 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:17 pm |
N/A 2031-06-30 |
Acumen Pharmaceuticals Inc. | ABOS | Fountain Nathan B Director |
34,000 | $0 | 34,000 (Direct) |
View |
Ownership |
2021-06-30 8:10 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Sands Capital Ventures Discovery Fund III L.P. Sands Capital Global Venture Fund II L.P. Sands Capital Life Sciences Pulse Fund LLC SANDS FRANK M. 10% Owner |
0 | $0 | 2,967,075 (Direct) |
View |
Ownership |
2021-06-30 7:12 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Hardie Robert D. 10% Owner |
0 | $0 | 3,201,156 (Indirect) |
View |
Ownership |
2021-06-30 7:11 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Manning Paul B 10% Owner |
0 | $0 | 3,698,178 (Indirect) |
View |
Ownership |
2021-06-30 6:59 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Stalfort John A III Director |
0 | $0 | 137,324 (Direct) |
View |
Ownership |
2021-06-30 6:58 pm |
N/A 2029-03-01 |
Acumen Pharmaceuticals Inc. | ABOS | Sevigny Jeffrey Director |
0 | $0 | 49,778 (Direct) |
View |
Ownership |
2021-06-30 6:57 pm |
N/A 2024-05-08 |
Acumen Pharmaceuticals Inc. | ABOS | Ives Jeffrey L. Director |
0 | $0 | 49,777 (Direct) |
View |
Ownership |
2021-06-30 6:55 pm |
N/A 2029-03-01 |
Acumen Pharmaceuticals Inc. | ABOS | Siemers Eric Chief Medical Officer |
0 | $0 | 497,789 (Direct) |
View |
Ownership |
2021-06-30 6:52 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | Zuga Matt Chief Financial Officer |
0 | $0 | 523,976 (Direct) |
View |
Ownership |
2021-06-30 6:51 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | OConnell Daniel Joseph President and CEO |
0 | $0 | 1,654,235 (Direct) |
View |
Ownership |
2021-06-30 6:49 pm |
N/A 2029-03-01 |
Acumen Pharmaceuticals Inc. | ABOS | Barton Russell Chief Operating Officer |
0 | $0 | 331,859 (Direct) |
View |
Ownership |
2021-06-30 6:03 pm |
N/A N/A |
Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 7,895,773 (Indirect) |
View |